nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2003-7-3-7-13nefr-926Research ArticleПЕРЕДОВАЯ СТАТЬЯLEADING ARTICLEАРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ КАК ФАКТОР РИСКА ПОВЫШЕННОЙ ЛЕТАЛЬНОСТИ У БОЛЬНЫХ, ПОЛУЧАЮЩИХ ЛЕЧЕНИЕ МЕТОДОМ ХРОНИЧЕСКОГО ГЕМОДИАЛИЗА, И ПОДХОДЫ К ЕЕ КОРРЕКЦИИARTERIAL HYPERTENSION AS A RISK FACTOR OF HIGHER MORTALITY IN CHRONIC HEMODIALYSIS PATIENTS AND APPROACHES TO ITS CORRECTIONСмирновА. В.SmirnovA. V.РыковВ. Г.RykovV. G.СуглобоваЕ. Д.SuglobovaE. D.ВасильевА. Н.VasilievA. N.Санкт-Петербургский государственный медицинский университет им. акад. И.П. ПавловаRussian Federation20031003200373713Copyright © Смирнов А.В., Рыков В.Г., Суглобова Е.Д., Васильев А.Н., 20032003Смирнов А.В., Рыков В.Г., Суглобова Е.Д., Васильев А.Н.Smirnov A.V., Rykov V.G., Suglobova E.D., Vasiliev A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/926

Артериальная гипертензия как фактор риска повышенной летальности у больных, получающих лечение методом хронического гемодиализа, и подходы к ее коррекции.

Arterial hypertension as a risk factor of higher mortality in chronic hemodialysis patients and approaches to its correction.

гемодиализартериальная гипертензиявыживаемостьлечениеhemodialysisarterial hypertensionsurvivaltreatmentReferencesLevey SA Eknoyan G. Cardiovascular disease in chronic renal disease. Nephrol Dial Transplant 1999; 14: 828-833Levey SA Eknoyan G. Cardiovascular disease in chronic renal disease. Nephrol Dial Transplant 1999; 14: 828-833US Renal Data System. Patients mortality and survival. Am J Kidney Dis 1995; 26 [Suppl 2] 69-84US Renal Data System. Patients mortality and survival. Am J Kidney Dis 1995; 26 [Suppl 2] 69-84Foley RN, Parfrey PS, Harnett JD. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney lnt 1995; 47: 186-192Foley RN, Parfrey PS, Harnett JD. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney lnt 1995; 47: 186-192Zucchelli P. The careful correction of renal insufficiency abnormalities: early is good. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 2-6Zucchelli P. The careful correction of renal insufficiency abnormalities: early is good. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 2-6Foley RN, Parfrey PS. Epidemiology of cardiovascular disease in chronic renal disease. Am Soc Nephrol 1998; 9: 16-23Foley RN, Parfrey PS. Epidemiology of cardiovascular disease in chronic renal disease. Am Soc Nephrol 1998; 9: 16-23Cohen ER Hypertension in chronic hemodialysis: viewing a paradox, and some notes on therapy. Dial & Transplant 2000; 29:535-542Cohen ER Hypertension in chronic hemodialysis: viewing a paradox, and some notes on therapy. Dial & Transplant 2000; 29:535-542Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int 2000; 58: 2147-2154Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int 2000; 58: 2147-2154Rahman M, Sehgal AR, Smith MC. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis 2000; 35: 257-265Rahman M, Sehgal AR, Smith MC. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis 2000; 35: 257-265Rocco MV, Yan G, Heyka RJ, Benz R, Cheung AK. Risk factors for hypertension in chronic haemodialysis patients: baseline data from the HEMO study. Am J Nephrol 2001; 21: 280-288Rocco MV, Yan G, Heyka RJ, Benz R, Cheung AK. Risk factors for hypertension in chronic haemodialysis patients: baseline data from the HEMO study. Am J Nephrol 2001; 21: 280-288Evert J Dorhout Mees. Hypertension in haemodialysis patients: who cares? Nephrol Dial Transplant 1999; 14: 28-30Evert J Dorhout Mees. Hypertension in haemodialysis patients: who cares? Nephrol Dial Transplant 1999; 14: 28-30Dhakal MP, Sloand JA. Prevalence of hypertension and adequacy of blood pressure control in hemodialysis patients. Dial & Transplant 2000; 29: 628-637Dhakal MP, Sloand JA. Prevalence of hypertension and adequacy of blood pressure control in hemodialysis patients. Dial & Transplant 2000; 29: 628-637Scribner BH. Can antihypertensive medications control BP in haemodialysis patients: yes or no. Nephrol Dial Transplant 1999; 14:2599-2601Scribner BH. Can antihypertensive medications control BP in haemodialysis patients: yes or no. Nephrol Dial Transplant 1999; 14:2599-2601Salem M. Hypertension in haemodialysis population: any relationship to 2-years survival? Nephrol Dial Transplant 1999; 14: 125-128Salem M. Hypertension in haemodialysis population: any relationship to 2-years survival? Nephrol Dial Transplant 1999; 14: 125-128Tozawa M et al. Hypertension in dialysis patients: a cross-sectional analysis. Nippon Jinzo Gakkai Shi 1996; 38: 129-135Tozawa M et al. Hypertension in dialysis patients: a cross-sectional analysis. Nippon Jinzo Gakkai Shi 1996; 38: 129-135Port FK, Hulbert-Shearon TE, Wolfe RA et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999; 33: 507-517Port FK, Hulbert-Shearon TE, Wolfe RA et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999; 33: 507-517Zager PG, Nikolic J et al. «U» curve association of blood pressure and mortality in haemodialysis patients. Kidney Int 1998;54:561-569Zager PG, Nikolic J et al. «U» curve association of blood pressure and mortality in haemodialysis patients. Kidney Int 1998;54:561-569Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States haemodialysis patients: USRDSWaves 3 and 4 Study. Kidneylnt 2002; 62: 1784-1790Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States haemodialysis patients: USRDSWaves 3 and 4 Study. Kidneylnt 2002; 62: 1784-1790Lowrie EG. Acute-phase inflammatory process contributed to malnutrition, anemia, and possibly other abnormalities in dialysis patients. Am J Kidney Dis 1998; 32 [Suppl 4]: 105-110Lowrie EG. Acute-phase inflammatory process contributed to malnutrition, anemia, and possibly other abnormalities in dialysis patients. Am J Kidney Dis 1998; 32 [Suppl 4]: 105-110Shinzato T, Naki S, Akiba T et al. Survival in long-term haemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1997; 12:889-898Shinzato T, Naki S, Akiba T et al. Survival in long-term haemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1997; 12:889-898Klassen PS, Lowrie EG, Reddan DN et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. J Am Med Assoc 2002; 287: 1548-1555Klassen PS, Lowrie EG, Reddan DN et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. J Am Med Assoc 2002; 287: 1548-1555Zoccali C. Arterial pressure components and cardiovascular risk in end-stage renal disease. Nephrol Dial Transplant 2003; 18: 249-252Zoccali C. Arterial pressure components and cardiovascular risk in end-stage renal disease. Nephrol Dial Transplant 2003; 18: 249-252Sytkowski PA, Kannel WB, D’Agnostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. New Eng J Med 1990; 322: 1635-1641Sytkowski PA, Kannel WB, D’Agnostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. New Eng J Med 1990; 322: 1635-1641Charra B, Laurent G, Calemard E, Terrat JC et al. Survival in dialysis and blood pressure control. Contrib Nephrol 1994; 106: 179-185Charra B, Laurent G, Calemard E, Terrat JC et al. Survival in dialysis and blood pressure control. Contrib Nephrol 1994; 106: 179-185Fisch BJ, Spiegel D. Assessment of excess fluid distribution in chronic haemodialysis patients using bioimpedance spectroscopy. Kidney Int 1996; 49: 1105-1109Fisch BJ, Spiegel D. Assessment of excess fluid distribution in chronic haemodialysis patients using bioimpedance spectroscopy. Kidney Int 1996; 49: 1105-1109Tomson C. Advising dialysis patients to restrict fluid intake without restricting sodium intake is not based on evidence and is a waste of time. Nephrol Dial Transplant 2001; 16:1538-1542Tomson C. Advising dialysis patients to restrict fluid intake without restricting sodium intake is not based on evidence and is a waste of time. Nephrol Dial Transplant 2001; 16:1538-1542Krautzig S. Dietary salt restriction and reduction of dialysate sodium to controle hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 1998; 13: 552-553Krautzig S. Dietary salt restriction and reduction of dialysate sodium to controle hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 1998; 13: 552-553Donohoe P1Farmer C, Dallyn P et al. Low-sodium hemodialysis without fluid removal improves blood pressure control in chronic dialysis patients. Kidney Int 1997; 52: 1110Donohoe P1Farmer C, Dallyn P et al. Low-sodium hemodialysis without fluid removal improves blood pressure control in chronic dialysis patients. Kidney Int 1997; 52: 1110Hamlyn JM, Hamilton BP, Manunta P. Endogenous oubain sodium balance and blood pressure: a review and hypothesis. J Hypertens 1996; 14: 151-167Hamlyn JM, Hamilton BP, Manunta P. Endogenous oubain sodium balance and blood pressure: a review and hypothesis. J Hypertens 1996; 14: 151-167Converse JR1 Jacobsen TN, Toto RD et al. Simpathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912-1918Converse JR1 Jacobsen TN, Toto RD et al. Simpathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912-1918Buoncristiani U. Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 2001; 16: 1538-1542Buoncristiani U. Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 2001; 16: 1538-1542Charra B, Calemard E, Laurent G. Importance of treatment time and blood pressure control in achieving longterm survival on dialysis. Am J Nephrol 1996; 16: 35-44Charra B, Calemard E, Laurent G. Importance of treatment time and blood pressure control in achieving longterm survival on dialysis. Am J Nephrol 1996; 16: 35-44Luik AJ, Charra B1 Katzarski K et al. Blood pressure control and hemodynamic changes in patients on long treatment time dialysis. J Am Soc Nephrol 1994; 5: 521-522Luik AJ, Charra B1 Katzarski K et al. Blood pressure control and hemodynamic changes in patients on long treatment time dialysis. J Am Soc Nephrol 1994; 5: 521-522Luik AJ, Sande FM, Weideman P et al. The influence of increasing dialysis treatment time and reducing dry weight on blood pressure control in haemodialysis patients: a prospective study. Am J Nephrol 2001; 21: 471-478Luik AJ, Sande FM, Weideman P et al. The influence of increasing dialysis treatment time and reducing dry weight on blood pressure control in haemodialysis patients: a prospective study. Am J Nephrol 2001; 21: 471-478Katzarski K, Charra B, Laurent G et al. Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 1999; 14: 369-375Katzarski K, Charra B, Laurent G et al. Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 1999; 14: 369-375Sherman RA, Daniel A, Cody RP.The effect of interdiaIytic weight gain on predialysis blood pressure. Artif Organs 1993; 17:770-774Sherman RA, Daniel A, Cody RP.The effect of interdiaIytic weight gain on predialysis blood pressure. Artif Organs 1993; 17:770-774Savage T, Fabbian F, Giles M, Tomson CR, Raine AE. Interdialytic weight gain and 48-h blood pressure in haemodialysis patients. Nephrol Dial Transplant 1997; 12: 2308-2311Savage T, Fabbian F, Giles M, Tomson CR, Raine AE. Interdialytic weight gain and 48-h blood pressure in haemodialysis patients. Nephrol Dial Transplant 1997; 12: 2308-2311Vaziri ND. Mechanism of erythropoietin-induced hypertension. Am J Kidney Dis 1999; 33: 821-828Vaziri ND. Mechanism of erythropoietin-induced hypertension. Am J Kidney Dis 1999; 33: 821-828Neff M, Kim K, Persoff M. Hemodynamics of uremic anemia. Circulation 1972; 46: 456-464Neff M, Kim K, Persoff M. Hemodynamics of uremic anemia. Circulation 1972; 46: 456-464Eschbach EJ, Abdulhadi MH, Browne JK et al. Recombinant human of erythropoietin in anemic patients with end-stage renal disease: results of phase III multicenter clinical trial. Ann Intern Med 1989; 111: 992-1000Eschbach EJ, Abdulhadi MH, Browne JK et al. Recombinant human of erythropoietin in anemic patients with end-stage renal disease: results of phase III multicenter clinical trial. Ann Intern Med 1989; 111: 992-1000

The authors declare that there are no conflicts of interest present.